Cargando…

Molecular monitoring of Plasmodium falciparum super-resistance to sulfadoxine–pyrimethamine in Tanzania

BACKGROUND: Sulfadoxine–pyrimethamine (SP) is recommended for prophylactic treatment of malaria in pregnancy while artemisinin combination therapy is the recommended first-line anti-malarial treatment. Selection of SP resistance is ongoing since SP is readily available in health facilities and in pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Kavishe, Reginald A., Kaaya, Robert D., Nag, Sidsel, Krogsgaard, Camilla, Notland, Jakob Ginsbak, Kavishe, Adellaida A., Ishengoma, Deus, Roper, Cally, Alifrangis, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4918075/
https://www.ncbi.nlm.nih.gov/pubmed/27339129
http://dx.doi.org/10.1186/s12936-016-1387-2
_version_ 1782439054197915648
author Kavishe, Reginald A.
Kaaya, Robert D.
Nag, Sidsel
Krogsgaard, Camilla
Notland, Jakob Ginsbak
Kavishe, Adellaida A.
Ishengoma, Deus
Roper, Cally
Alifrangis, Michael
author_facet Kavishe, Reginald A.
Kaaya, Robert D.
Nag, Sidsel
Krogsgaard, Camilla
Notland, Jakob Ginsbak
Kavishe, Adellaida A.
Ishengoma, Deus
Roper, Cally
Alifrangis, Michael
author_sort Kavishe, Reginald A.
collection PubMed
description BACKGROUND: Sulfadoxine–pyrimethamine (SP) is recommended for prophylactic treatment of malaria in pregnancy while artemisinin combination therapy is the recommended first-line anti-malarial treatment. Selection of SP resistance is ongoing since SP is readily available in health facilities and in private drug shops in sub-Saharan Africa. This study reports on the prevalence and distribution of Pfdhps mutations A540E and A581G in Tanzania. When found together, these mutations confer high-level SP resistance (sometimes referred to as ‘super-resistance’), which is associated with loss in protective efficacy of SP-IPTp. METHODS: DNA samples were extracted from malaria-positive blood samples on filter paper, used malaria rapid diagnostic test strips and whole blood collected from eight sites in seven administrative regions of Tanzania. PCR–RFLP and SSOP-ELISA techniques were used to genotype the A540E and A581G Pfdhps. Data were analysed using SPSS version 18 while Chi square and/or Fischer Exact tests were used to compare prevalence between regions. RESULTS: A high inter-regional variation of Pfdhps-540E was observed (χ(2) = 76.8, p < 0.001). High inter-regional variation of 581G was observed (FE = 85.3, p < 0.001). Both Tanga and Kagera were found to have the highest levels of SP resistance. A high prevalence of Pfdhps-581G was observed in Tanga (56.6 %) in northeastern Tanzania and in Kagera (20.4 %) in northwestern Tanzania and the 540–581 EG haplotype was found at 54.5 and 19.4 %, respectively. Pfdhps-581G was not detected in Pwani and Lindi regions located south of Tanga region. CONCLUSIONS: Selection of SP super-resistant Pfdhps A581G is highest in northern Tanzania. Variation in distribution of SP resistance is observed across the country: northeastern Tanga region and northwestern Kagera region have highest prevalence of SP super-resistance markers, while in Pwani and Lindi in the southeast the prevalence of super-resistance was zero. More studies should be conducted to understand the factors underlying the remarkable heterogeneity in SP resistance in the country.
format Online
Article
Text
id pubmed-4918075
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-49180752016-06-24 Molecular monitoring of Plasmodium falciparum super-resistance to sulfadoxine–pyrimethamine in Tanzania Kavishe, Reginald A. Kaaya, Robert D. Nag, Sidsel Krogsgaard, Camilla Notland, Jakob Ginsbak Kavishe, Adellaida A. Ishengoma, Deus Roper, Cally Alifrangis, Michael Malar J Research BACKGROUND: Sulfadoxine–pyrimethamine (SP) is recommended for prophylactic treatment of malaria in pregnancy while artemisinin combination therapy is the recommended first-line anti-malarial treatment. Selection of SP resistance is ongoing since SP is readily available in health facilities and in private drug shops in sub-Saharan Africa. This study reports on the prevalence and distribution of Pfdhps mutations A540E and A581G in Tanzania. When found together, these mutations confer high-level SP resistance (sometimes referred to as ‘super-resistance’), which is associated with loss in protective efficacy of SP-IPTp. METHODS: DNA samples were extracted from malaria-positive blood samples on filter paper, used malaria rapid diagnostic test strips and whole blood collected from eight sites in seven administrative regions of Tanzania. PCR–RFLP and SSOP-ELISA techniques were used to genotype the A540E and A581G Pfdhps. Data were analysed using SPSS version 18 while Chi square and/or Fischer Exact tests were used to compare prevalence between regions. RESULTS: A high inter-regional variation of Pfdhps-540E was observed (χ(2) = 76.8, p < 0.001). High inter-regional variation of 581G was observed (FE = 85.3, p < 0.001). Both Tanga and Kagera were found to have the highest levels of SP resistance. A high prevalence of Pfdhps-581G was observed in Tanga (56.6 %) in northeastern Tanzania and in Kagera (20.4 %) in northwestern Tanzania and the 540–581 EG haplotype was found at 54.5 and 19.4 %, respectively. Pfdhps-581G was not detected in Pwani and Lindi regions located south of Tanga region. CONCLUSIONS: Selection of SP super-resistant Pfdhps A581G is highest in northern Tanzania. Variation in distribution of SP resistance is observed across the country: northeastern Tanga region and northwestern Kagera region have highest prevalence of SP super-resistance markers, while in Pwani and Lindi in the southeast the prevalence of super-resistance was zero. More studies should be conducted to understand the factors underlying the remarkable heterogeneity in SP resistance in the country. BioMed Central 2016-06-23 /pmc/articles/PMC4918075/ /pubmed/27339129 http://dx.doi.org/10.1186/s12936-016-1387-2 Text en © The Author(s) 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Kavishe, Reginald A.
Kaaya, Robert D.
Nag, Sidsel
Krogsgaard, Camilla
Notland, Jakob Ginsbak
Kavishe, Adellaida A.
Ishengoma, Deus
Roper, Cally
Alifrangis, Michael
Molecular monitoring of Plasmodium falciparum super-resistance to sulfadoxine–pyrimethamine in Tanzania
title Molecular monitoring of Plasmodium falciparum super-resistance to sulfadoxine–pyrimethamine in Tanzania
title_full Molecular monitoring of Plasmodium falciparum super-resistance to sulfadoxine–pyrimethamine in Tanzania
title_fullStr Molecular monitoring of Plasmodium falciparum super-resistance to sulfadoxine–pyrimethamine in Tanzania
title_full_unstemmed Molecular monitoring of Plasmodium falciparum super-resistance to sulfadoxine–pyrimethamine in Tanzania
title_short Molecular monitoring of Plasmodium falciparum super-resistance to sulfadoxine–pyrimethamine in Tanzania
title_sort molecular monitoring of plasmodium falciparum super-resistance to sulfadoxine–pyrimethamine in tanzania
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4918075/
https://www.ncbi.nlm.nih.gov/pubmed/27339129
http://dx.doi.org/10.1186/s12936-016-1387-2
work_keys_str_mv AT kavishereginalda molecularmonitoringofplasmodiumfalciparumsuperresistancetosulfadoxinepyrimethamineintanzania
AT kaayarobertd molecularmonitoringofplasmodiumfalciparumsuperresistancetosulfadoxinepyrimethamineintanzania
AT nagsidsel molecularmonitoringofplasmodiumfalciparumsuperresistancetosulfadoxinepyrimethamineintanzania
AT krogsgaardcamilla molecularmonitoringofplasmodiumfalciparumsuperresistancetosulfadoxinepyrimethamineintanzania
AT notlandjakobginsbak molecularmonitoringofplasmodiumfalciparumsuperresistancetosulfadoxinepyrimethamineintanzania
AT kavisheadellaidaa molecularmonitoringofplasmodiumfalciparumsuperresistancetosulfadoxinepyrimethamineintanzania
AT ishengomadeus molecularmonitoringofplasmodiumfalciparumsuperresistancetosulfadoxinepyrimethamineintanzania
AT ropercally molecularmonitoringofplasmodiumfalciparumsuperresistancetosulfadoxinepyrimethamineintanzania
AT alifrangismichael molecularmonitoringofplasmodiumfalciparumsuperresistancetosulfadoxinepyrimethamineintanzania